aluates Reports

$ 0.0

Automative

Pediatric Anti-Flu Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: October 2024

Report Code: QYRE-Auto-35E18185

BUY CHAPTERS

Pediatric Anti-Flu Drugs - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-35E18185

Report

October 2024

Pages:106

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Roche

Johnson & Johnson

GlaxoSmithKline(GSK )

Rostec

Cipla Ltd

Pediatric Anti-Flu Drugs - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Pediatric Anti-Flu Drugs - Market

The global market for Pediatric Anti-Flu Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Pediatric Anti-Flu Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pediatric Anti-Flu Drugs by region & country, by Type, and by Application.

The Pediatric Anti-Flu Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Anti-Flu Drugs.

Market Segmentation

Scope of Pediatric Anti-Flu Drugs - Market Report

Report Metric	Details
Report Name	Pediatric Anti-Flu Drugs - Market
CAGR	5%
Segment by Type:	Oseltamivir Zanamivir
Segment by Application	Hospital Clinic Online Sales Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche, Johnson & Johnson, GlaxoSmithKline (GSK), Rostec, Cipla
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pediatric Anti-Flu Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pediatric Anti-Flu Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pediatric Anti-Flu Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Pediatric Anti-Flu Drugs - Market report?

Ans: The main players in the Pediatric Anti-Flu Drugs - Market are Roche, Johnson & Johnson, GlaxoSmithKline (GSK), Rostec, Cipla

What are the Application segmentation covered in the Pediatric Anti-Flu Drugs - Market report?

Ans: The Applications covered in the Pediatric Anti-Flu Drugs - Market report are Hospital, Clinic, Online Sales, Others

What are the Type segmentation covered in the Pediatric Anti-Flu Drugs - Market report?

Ans: The Types covered in the Pediatric Anti-Flu Drugs - Market report are Oseltamivir, Zanamivir

1 Market Overview

1.1 Pediatric Anti-Flu Drugs Product Introduction

1.2 Global Pediatric Anti-Flu Drugs Market Size Forecast

1.2.1 Global Pediatric Anti-Flu Drugs Sales Value (2019-2030)

1.2.2 Global Pediatric Anti-Flu Drugs Sales Volume (2019-2030)

1.2.3 Global Pediatric Anti-Flu Drugs Sales Price (2019-2030)

1.3 Pediatric Anti-Flu Drugs Market Trends & Drivers

1.3.1 Pediatric Anti-Flu Drugs Industry Trends

1.3.2 Pediatric Anti-Flu Drugs Market Drivers & Opportunity

1.3.3 Pediatric Anti-Flu Drugs Market Challenges

1.3.4 Pediatric Anti-Flu Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Pediatric Anti-Flu Drugs Players Revenue Ranking (2023)

2.2 Global Pediatric Anti-Flu Drugs Revenue by Company (2019-2024)

2.3 Global Pediatric Anti-Flu Drugs Players Sales Volume Ranking (2023)

2.4 Global Pediatric Anti-Flu Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Pediatric Anti-Flu Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Pediatric Anti-Flu Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Pediatric Anti-Flu Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Pediatric Anti-Flu Drugs

2.9 Pediatric Anti-Flu Drugs Market Competitive Analysis

2.9.1 Pediatric Anti-Flu Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Pediatric Anti-Flu Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Anti-Flu Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Oseltamivir

3.1.2 Zanamivir

3.2 Global Pediatric Anti-Flu Drugs Sales Value by Type

3.2.1 Global Pediatric Anti-Flu Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Pediatric Anti-Flu Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Pediatric Anti-Flu Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Pediatric Anti-Flu Drugs Sales Volume by Type

3.3.1 Global Pediatric Anti-Flu Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Pediatric Anti-Flu Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Pediatric Anti-Flu Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Pediatric Anti-Flu Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.1.3 Online Sales

4.1.4 Others

4.2 Global Pediatric Anti-Flu Drugs Sales Value by Application

4.2.1 Global Pediatric Anti-Flu Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Pediatric Anti-Flu Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Pediatric Anti-Flu Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Pediatric Anti-Flu Drugs Sales Volume by Application

4.3.1 Global Pediatric Anti-Flu Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Pediatric Anti-Flu Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Pediatric Anti-Flu Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Pediatric Anti-Flu Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Pediatric Anti-Flu Drugs Sales Value by Region

5.1.1 Global Pediatric Anti-Flu Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Pediatric Anti-Flu Drugs Sales Value by Region (2019-2024)

5.1.3 Global Pediatric Anti-Flu Drugs Sales Value by Region (2025-2030)

5.1.4 Global Pediatric Anti-Flu Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Pediatric Anti-Flu Drugs Sales Volume by Region

5.2.1 Global Pediatric Anti-Flu Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Pediatric Anti-Flu Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Pediatric Anti-Flu Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Pediatric Anti-Flu Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Pediatric Anti-Flu Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Pediatric Anti-Flu Drugs Sales Value, 2019-2030

5.4.2 North America Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Pediatric Anti-Flu Drugs Sales Value, 2019-2030

5.5.2 Europe Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Pediatric Anti-Flu Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Pediatric Anti-Flu Drugs Sales Value, 2019-2030

5.7.2 South America Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Pediatric Anti-Flu Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Pediatric Anti-Flu Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Pediatric Anti-Flu Drugs Sales Value

6.2.1 Key Countries/Regions Pediatric Anti-Flu Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Pediatric Anti-Flu Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Pediatric Anti-Flu Drugs Sales Value, 2019-2030

6.3.2 United States Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Pediatric Anti-Flu Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Pediatric Anti-Flu Drugs Sales Value, 2019-2030

6.4.2 Europe Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Pediatric Anti-Flu Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Pediatric Anti-Flu Drugs Sales Value, 2019-2030

6.5.2 China Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Pediatric Anti-Flu Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Pediatric Anti-Flu Drugs Sales Value, 2019-2030

6.6.2 Japan Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Pediatric Anti-Flu Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Pediatric Anti-Flu Drugs Sales Value, 2019-2030

6.7.2 South Korea Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Pediatric Anti-Flu Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Pediatric Anti-Flu Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Pediatric Anti-Flu Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Pediatric Anti-Flu Drugs Sales Value, 2019-2030

6.9.2 India Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Pediatric Anti-Flu Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Roche

7.1.1 Roche Company Information

7.1.2 Roche Introduction and Business Overview

7.1.3 Roche Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Roche Pediatric Anti-Flu Drugs Product Offerings

7.1.5 Roche Recent Development

7.2 Johnson & Johnson

7.2.1 Johnson & Johnson Company Information

7.2.2 Johnson & Johnson Introduction and Business Overview

7.2.3 Johnson & Johnson Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Johnson & Johnson Pediatric Anti-Flu Drugs Product Offerings

7.2.5 Johnson & Johnson Recent Development

7.3 GlaxoSmithKline (GSK)

7.3.1 GlaxoSmithKline (GSK) Company Information

7.3.2 GlaxoSmithKline (GSK) Introduction and Business Overview

7.3.3 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product Offerings

7.3.5 GlaxoSmithKline (GSK) Recent Development

7.4 Rostec

7.4.1 Rostec Company Information

7.4.2 Rostec Introduction and Business Overview

7.4.3 Rostec Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Rostec Pediatric Anti-Flu Drugs Product Offerings

7.4.5 Rostec Recent Development

7.5 Cipla

7.5.1 Cipla Company Information

7.5.2 Cipla Introduction and Business Overview

7.5.3 Cipla Pediatric Anti-Flu Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Cipla Pediatric Anti-Flu Drugs Product Offerings

7.5.5 Cipla Recent Development

8 Industry Chain Analysis

8.1 Pediatric Anti-Flu Drugs Industrial Chain

8.2 Pediatric Anti-Flu Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Pediatric Anti-Flu Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Pediatric Anti-Flu Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Roche

Johnson & Johnson

GlaxoSmithKline(GSK )

Rostec

Cipla Ltd

List of Tables

Table 1. Pediatric Anti-Flu Drugs Market Trends

Table 2. Pediatric Anti-Flu Drugs Market Drivers & Opportunity

Table 3. Pediatric Anti-Flu Drugs Market Challenges

Table 4. Pediatric Anti-Flu Drugs Market Restraints

Table 5. Global Pediatric Anti-Flu Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Pediatric Anti-Flu Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Pediatric Anti-Flu Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Pediatric Anti-Flu Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Pediatric Anti-Flu Drugs Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Pediatric Anti-Flu Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Pediatric Anti-Flu Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Pediatric Anti-Flu Drugs

Table 13. Global Pediatric Anti-Flu Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Anti-Flu Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Pediatric Anti-Flu Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Pediatric Anti-Flu Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Pediatric Anti-Flu Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Pediatric Anti-Flu Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Pediatric Anti-Flu Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Pediatric Anti-Flu Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Pediatric Anti-Flu Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Pediatric Anti-Flu Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Pediatric Anti-Flu Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Pediatric Anti-Flu Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Pediatric Anti-Flu Drugs Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Pediatric Anti-Flu Drugs Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Pediatric Anti-Flu Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Pediatric Anti-Flu Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Pediatric Anti-Flu Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Pediatric Anti-Flu Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Pediatric Anti-Flu Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Pediatric Anti-Flu Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Pediatric Anti-Flu Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Pediatric Anti-Flu Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Pediatric Anti-Flu Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Pediatric Anti-Flu Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Pediatric Anti-Flu Drugs Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Pediatric Anti-Flu Drugs Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Pediatric Anti-Flu Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Pediatric Anti-Flu Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Pediatric Anti-Flu Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Pediatric Anti-Flu Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Pediatric Anti-Flu Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Pediatric Anti-Flu Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Pediatric Anti-Flu Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Pediatric Anti-Flu Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Pediatric Anti-Flu Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Pediatric Anti-Flu Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Pediatric Anti-Flu Drugs Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Pediatric Anti-Flu Drugs Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Pediatric Anti-Flu Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Pediatric Anti-Flu Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Pediatric Anti-Flu Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Pediatric Anti-Flu Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Pediatric Anti-Flu Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Roche Company Information

Table 58. Roche Introduction and Business Overview

Table 59. Roche Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Roche Pediatric Anti-Flu Drugs Product Offerings

Table 61. Roche Recent Development

Table 62. Johnson & Johnson Company Information

Table 63. Johnson & Johnson Introduction and Business Overview

Table 64. Johnson & Johnson Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Johnson & Johnson Pediatric Anti-Flu Drugs Product Offerings

Table 66. Johnson & Johnson Recent Development

Table 67. GlaxoSmithKline (GSK) Company Information

Table 68. GlaxoSmithKline (GSK) Introduction and Business Overview

Table 69. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. GlaxoSmithKline (GSK) Pediatric Anti-Flu Drugs Product Offerings

Table 71. GlaxoSmithKline (GSK) Recent Development

Table 72. Rostec Company Information

Table 73. Rostec Introduction and Business Overview

Table 74. Rostec Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Rostec Pediatric Anti-Flu Drugs Product Offerings

Table 76. Rostec Recent Development

Table 77. Cipla Company Information

Table 78. Cipla Introduction and Business Overview

Table 79. Cipla Pediatric Anti-Flu Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Cipla Pediatric Anti-Flu Drugs Product Offerings

Table 81. Cipla Recent Development

Table 82. Key Raw Materials Lists

Table 83. Raw Materials Key Suppliers Lists

Table 84. Pediatric Anti-Flu Drugs Downstream Customers

Table 85. Pediatric Anti-Flu Drugs Distributors List

Table 86. Research Programs/Design for This Report

Table 87. Key Data Information from Secondary Sources

Table 88. Key Data Information from Primary Sources

List of Figures

Figure 1. Pediatric Anti-Flu Drugs Product Picture

Figure 2. Global Pediatric Anti-Flu Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Pediatric Anti-Flu Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Pediatric Anti-Flu Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Pediatric Anti-Flu Drugs Sales Price (2019-2030) & (US$/Unit)

Figure 6. Pediatric Anti-Flu Drugs Report Years Considered

Figure 7. Global Pediatric Anti-Flu Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Pediatric Anti-Flu Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Pediatric Anti-Flu Drugs Revenue in 2023

Figure 10. Pediatric Anti-Flu Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Oseltamivir Picture

Figure 12. Zanamivir Picture

Figure 13. Global Pediatric Anti-Flu Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Pediatric Anti-Flu Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Pediatric Anti-Flu Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Pediatric Anti-Flu Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Pediatric Anti-Flu Drugs Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Clinic

Figure 20. Product Picture of Online Sales

Figure 21. Product Picture of Others

Figure 22. Global Pediatric Anti-Flu Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 23. Global Pediatric Anti-Flu Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 24. Global Pediatric Anti-Flu Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 25. Global Pediatric Anti-Flu Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 26. Global Pediatric Anti-Flu Drugs Price by Application (2019-2030) & (US$/Unit)

Figure 27. North America Pediatric Anti-Flu Drugs Sales Value (2019-2030) & (US$ Million)

Figure 28. North America Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

Figure 29. Europe Pediatric Anti-Flu Drugs Sales Value (2019-2030) & (US$ Million)

Figure 30. Europe Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

Figure 31. Asia Pacific Pediatric Anti-Flu Drugs Sales Value (2019-2030) & (US$ Million)

Figure 32. Asia Pacific Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

Figure 33. South America Pediatric Anti-Flu Drugs Sales Value (2019-2030) & (US$ Million)

Figure 34. South America Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

Figure 35. Middle East & Africa Pediatric Anti-Flu Drugs Sales Value (2019-2030) & (US$ Million)

Figure 36. Middle East & Africa Pediatric Anti-Flu Drugs Sales Value by Country (%), 2023 VS 2030

Figure 37. Key Countries/Regions Pediatric Anti-Flu Drugs Sales Value (%), (2019-2030)

Figure 38. Key Countries/Regions Pediatric Anti-Flu Drugs Sales Volume (%), (2019-2030)

Figure 39. United States Pediatric Anti-Flu Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 40. United States Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

Figure 41. United States Pediatric Anti-Flu Drugs Sales Value by Application (%), 2023 VS 2030

Figure 42. Europe Pediatric Anti-Flu Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 43. Europe Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

Figure 44. Europe Pediatric Anti-Flu Drugs Sales Value by Application (%), 2023 VS 2030

Figure 45. China Pediatric Anti-Flu Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 46. China Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

Figure 47. China Pediatric Anti-Flu Drugs Sales Value by Application (%), 2023 VS 2030

Figure 48. Japan Pediatric Anti-Flu Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 49. Japan Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

Figure 50. Japan Pediatric Anti-Flu Drugs Sales Value by Application (%), 2023 VS 2030

Figure 51. South Korea Pediatric Anti-Flu Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 52. South Korea Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

Figure 53. South Korea Pediatric Anti-Flu Drugs Sales Value by Application (%), 2023 VS 2030

Figure 54. Southeast Asia Pediatric Anti-Flu Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 55. Southeast Asia Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

Figure 56. Southeast Asia Pediatric Anti-Flu Drugs Sales Value by Application (%), 2023 VS 2030

Figure 57. India Pediatric Anti-Flu Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 58. India Pediatric Anti-Flu Drugs Sales Value by Type (%), 2023 VS 2030

Figure 59. India Pediatric Anti-Flu Drugs Sales Value by Application (%), 2023 VS 2030

Figure 60. Pediatric Anti-Flu Drugs Industrial Chain

Figure 61. Pediatric Anti-Flu Drugs Manufacturing Cost Structure

Figure 62. Channels of Distribution (Direct Sales, and Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions